— EXPAREL is the only FDA-approved single-dose regional analgesic to safely demonstrate four days of superiority versus bupivacaine in two clinical studies — — New indications for use as an adductor ...
Please provide your email address to receive an email when new articles are posted on . Use of liposomal bupivacaine in an interscalene nerve block effectively controlled pain after outpatient ...
About Pacira Pacira delivers innovative, non-opioid pain therapies to transform the lives of patients. Pacira has three ...
The Food and Drug Administration (FDA) has approved the use of Exparel (bupivacaine liposome injectable suspension; Pacira Pharmaceuticals) as an interscalene brachial plexus block to produce ...
Patients who received interscalene brachial plexus block plus soft tissue infiltration with Exparel when undergoing primary shoulder arthroplasty used significantly more narcotics postoperatively and ...
Announcing a new article publication for BIO Integration journal. In this article the authors Daowei Lin, Zhixiao Han, Yanni Fu, Xiaoqiu Zhu, Jin Li, Hui Xu, Jing Wen, Fei Wang and Mingyan Guo from ...
TAMPA, Fla., March 29, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today ...
The Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for Exparel (bupivacaine liposome injectable suspension) to include both single-dose sciatic nerve ...
Nerve blocks are used for pain treatment and management. Often a group of nerves, called a plexus or ganglion, that causes pain to a specific organ or body region can be blocked with the injection of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback